about
Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases.Breast cancer and circadian disruption from electric lighting in the modern worldThe aging clock and circadian control of metabolism and genome stabilityRegulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at nightMelatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude ratsAge-related decline in melatonin and its MT1 receptor are associated with decreased sensitivity to melatonin and enhanced mammary tumor growthRandomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119)New actions of melatonin on tumor metabolism and growth.Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer.Light exposure at night disrupts host/cancer circadian regulatory dynamics: impact on the Warburg effect, lipid signaling and tumor growth preventionLight during darkness, melatonin suppression and cancer progression.Dark-phase light contamination disrupts circadian rhythms in plasma measures of endocrine physiology and metabolism in rats.Polyunsaturated fatty acids, melatonin, and cancer prevention.Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy.Eliminating animal facility light-at-night contamination and its effect on circadian regulation of rodent physiology, tumor growth, and metabolism: a challenge in the relocation of a cancer research laboratory.The influence of red light exposure at night on circadian metabolism and physiology in Sprague-Dawley rats.Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night.Breast cancer: a model system for studying the neuroendocrine role of pineal melatonin in oncology.Melatonin: an inhibitor of breast cancer.Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signalA new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude rats.Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in cultureImpaired mouse mammary gland growth and development is mediated by melatonin and its MT1G protein-coupled receptor via repression of ERα, Akt1, and Stat5Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal.Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β.Daytime Blue Light Enhances the Nighttime Circadian Melatonin Inhibition of Human Prostate Cancer GrowthLight during darkness and cancer: relationships in circadian photoreception and tumor biology.Effects of spectral transmittance through standard laboratory cages on circadian metabolism and physiology in nude rats.Dietary factors and growth and metabolism in experimental tumors.Health consequences of electric lighting practices in the modern world: a report on the National Toxicology Program's workshop on shift work at night, artificial light at night, and circadian disruptionMolecular deficiency (ies) in MT₁ melatonin signaling pathway underlies the melatonin-unresponsive phenotype in MDA-MB-231 human breast cancer cells.Insulin and IGF1 enhance IL-17-induced chemokine expression through a GSK3B-dependent mechanism: a new target for melatonin's anti-inflammatory action.Effect of spectral transmittance through red-tinted rodent cages on circadian metabolism and physiology in nude rats.Melatonin, sleep disturbance and cancer risk.Effects of Daytime Exposure to Light from Blue-Enriched Light-Emitting Diodes on the Nighttime Melatonin Amplitude and Circadian Regulation of Rodent Metabolism and Physiology.Effects of Colored Enrichment Devices on Circadian Metabolism and Physiology in Male Sprague-Dawley Rats.Effect of different spectral transmittances through tinted animal cages on circadian metabolism and physiology in Sprague-Dawley rats.Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer.Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression.Prolactin-releasing and release-inhibiting factor activities in the bovine, rat, and human pineal gland: in vitro and in vivo studies.
P50
Q24670218-AEFBCDCD-30AA-46F0-BE0E-3375D0E74B89Q26823410-4049C799-A37C-416F-BF65-671A4E3C7961Q28087454-BFB43166-5731-4364-81F3-43E574059B9BQ28241693-14BB32D3-1ED5-4E2A-A3B7-F377EC26032FQ28284736-7A8B7222-C59F-420E-8B56-93AF42EE10EBQ28580741-0231AC8E-6EDA-47CB-B0EA-6BF07AFDC689Q30439202-8AA5FE82-21E1-43E8-A06D-A685AC4EEEA8Q33543305-476E4F56-C2ED-4B9F-A67A-A2BB4E1A286EQ33992390-B5691BF3-21AF-488D-9283-1B93B16DAFD8Q34010850-100C21F3-CA77-4D66-9097-67CC1735C396Q34143048-096195F2-5193-4203-841B-5FD6AC1C7ABBQ34217396-0A1847F3-F2DC-492D-916E-5837440E31F6Q34264080-2092AA61-B6BC-42D7-90D2-5E46F13B8B8EQ34567176-35ECA683-F942-4CC5-96FA-F03747A9F5FAQ35010786-10EBCAEC-6344-4200-A996-614A4274FCE3Q35031090-A71DB06E-2C13-4B6D-867D-F3BC763C9C1EQ35181910-AE78C658-4BCF-4A61-BC55-F07D0B501B95Q35378005-2D83622C-3F6E-450E-B677-51EFBA58940CQ35689110-298A4B7B-C59A-4FD6-B3B0-B9034F1E8A2CQ35815736-54028F8E-761A-499D-A939-74B549EB00E7Q35867113-59171ECA-B9E2-4A07-A7FC-9848C5843622Q36081796-32DB67A5-D9B9-421B-9FF8-4FF93C2E4E6FQ36174451-65DF920A-EF9D-4F23-A69D-3B57CF23CBDBQ36282835-94336272-45E9-4A60-A994-153ECBA99369Q36367178-B95A6E98-72AF-46E5-9B5A-2418D185ADD1Q36376965-81BC516B-D334-480A-B7F7-4E94AEFB52F0Q36441043-4B689E8D-C6CA-4D57-9181-C0961908D48AQ36761182-11C770E5-EF60-4886-B60D-089ABBD42A54Q36785444-3E101FF2-D792-4566-BBF2-DC2132F5D6CEQ36887762-10546027-DB85-4C67-9D7F-1BA47CC2EEA1Q36904849-46828E61-8DAC-4334-89DF-206836F7DA78Q37230842-60D3C30C-A616-4DD9-ACB1-936844A94C8DQ37337647-1F20BF43-557F-4CCD-851E-8D52F7F6829DQ37354527-D046CC22-6341-4752-B1E7-12EF3FB8B7F9Q37354941-ED8E8E93-CB41-4D72-9B94-8E0906BC4400Q37354945-4EC0BF49-AF7B-4FF3-B82C-328723AF5674Q37489611-6B5394B3-31E3-4794-A26F-DDC8BDD927B7Q37902966-97FBEF90-5232-475B-864F-77CF8EAE352CQ38734026-42C02C94-EAC3-46EC-BB76-7ADBB75A31D6Q39103126-E133D89F-A077-4540-85DB-E1B89A7001AE
P50
name
David E. Blask
@en
type
label
David E. Blask
@en
prefLabel
David E. Blask
@en